The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 183, doi. 10.1177/03331024211042360
- By:
- Publication type:
- Article
Works matching IS 03331024 AND DT 2022 AND VI 42 AND IP 3
Results: 12
1
2
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 218, doi. 10.1177/03331024211040753
- By:
- Publication type:
- Article
3
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 186, doi. 10.1177/03331024211040467
- By:
- Publication type:
- Article
4
Validity of the Severity of Dependence Scale for detecting dependence behaviours in chronic migraine with medication overuse.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 209, doi. 10.1177/03331024211039817
- By:
- Publication type:
- Article
5
A prolactin-dependent sexually dimorphic mechanism of migraine chronification.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 197, doi. 10.1177/03331024211039813
- By:
- Publication type:
- Article
6
Update on "Treatment of orthostatic headache without intracranial hypotension: A case report" – nine years later.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
7
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 266, doi. 10.1177/03331024211038654
- By:
- Publication type:
- Article
8
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future research.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 262, doi. 10.1177/03331024211038526
- By:
- Publication type:
- Article
9
Could erectile dysfunction be a side effect of CGRP inhibition? A case report.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 257, doi. 10.1177/03331024211037304
- By:
- Publication type:
- Article
10
Quality appraisal of existing guidelines for the management of headache disorders by the AGREE II's method.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 239, doi. 10.1177/03331024211037297
- By:
- Publication type:
- Article
11
Reversible cerebral vasoconstriction syndrome developing after an erenumab injection for migraine prevention.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
12
Genome-wide association study reveals susceptibility loci for self-reported headache in a large community-based Asian population.
- Published in:
- Cephalalgia, 2022, v. 42, n. 3, p. 229, doi. 10.1177/03331024211037269
- By:
- Publication type:
- Article